Poxel Reports Financial Update for Cash and Revenue for the Full Year 2021 and Provides Corporate Update Feb 16, 2022
Poxel Announces PXL065 Granted FDA Fast Track Designation for X-linked Adrenoleukodystrophy Feb 16, 2022
Poxel Announces its Participation at Upcoming Investor and Scientific Conferences in January 2022 Dec 14, 2021
Poxel Announces the Formation of its Scientific Advisory Board for Rare Metabolic Diseases Dec 6, 2021
Poxel Announces its Participation at Upcoming Investor and Scientific Conferences in November Nov 3, 2021
Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2021 Oct 20, 2021
Poxel Announces its Participation at Upcoming Scientific Conferences Related to Adrenoleukodystrophy (ALD) Sep 27, 2021
